Clobetop S3 Ointment
By Clobetop S
Rx
30gm Ointment in a Tube

Composition
Clobetasol(0.05% w/v) + Salicylic Acid(3% w/v)

Manufacturer - JVJ Pharmaceuticals Pvt Ltd
J. V. J. Pharmaceuticals Private Limited, 218, Chetak Centre Annex, 12/2, Rabindranath Tagore Marg, Indore-452001, Madhya Pradesh, India

Expires on or after
September, 2025

liver
When considering the safety of using Clobetop S3 Ointment in relation to the liver, it is important to note that no interactions or established information have been found. This suggests that there is currently no specific safety advice or concerns regarding the use of this ointment and its impact on the liver. As such, there are no known risks or precautions related to liver issues when using Clobetop S3 Ointment. However, it is always recommended to consult with your doctor for proper guidance before using any new medication or ointment, especially if you have existing liver conditions or concerns.

kidney
No interaction has been found or established concerning kidney issues with Clobetop S3 Ointment. Consult with your doctor for proper guidance before using Clobetop S3 Ointment.

alcohol
No interaction has been found between alcohol and Clobetop S3 Ointment. It is always important to consult a healthcare professional before using any medication while pregnant.

driving
Safety advice regarding driving while using Clobetop S3 Ointment No interactions have been found or established.

pregnancy
Clobetop S3 Ointment might not be safe to use during pregnancy. Limited human studies, and animal studies, suggest possible harm to the baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Clobetop S3 Ointment is likely safe for use during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | DERMA |
Action Class | - |
₹89
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024